These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 31069492)
21. Deletions on chromosome 22 in sporadic meningioma. Ruttledge MH; Xie YG; Han FY; Peyrard M; Collins VP; Nordenskjöld M; Dumanski JP Genes Chromosomes Cancer; 1994 Jun; 10(2):122-30. PubMed ID: 7520265 [TBL] [Abstract][Full Text] [Related]
22. Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence. Katz LM; Hielscher T; Liechty B; Silverman J; Zagzag D; Sen R; Wu P; Golfinos JG; Reuss D; Neidert MC; Wirsching HG; Baumgarten P; Herold-Mende C; Wick W; Harter PN; Weller M; von Deimling A; Snuderl M; Sen C; Sahm F Acta Neuropathol; 2018 Jun; 135(6):955-963. PubMed ID: 29627952 [TBL] [Abstract][Full Text] [Related]
23. DNA methylation profiling of meningiomas highlights clinically distinct molecular subgroups. Singh J; Sharma R; Shukla N; Narwal P; Katiyar A; Mahajan S; Sahu S; Garg A; Sharma MC; Suri A; Sarkar C; Suri V J Neurooncol; 2023 Jan; 161(2):339-356. PubMed ID: 36564673 [TBL] [Abstract][Full Text] [Related]
24. Quantitative analysis of neurofibromatosis type 2 gene transcripts in meningiomas supports the concept of distinct molecular variants. Wellenreuther R; Waha A; Vogel Y; Lenartz D; Schramm J; Wiestler OD; von Deimling A Lab Invest; 1997 Dec; 77(6):601-6. PubMed ID: 9426397 [TBL] [Abstract][Full Text] [Related]
25. Advances in Molecular Classification and Therapeutic Opportunities in Meningiomas. Cordova C; Kurz SC Curr Oncol Rep; 2020 Jul; 22(8):84. PubMed ID: 32617743 [TBL] [Abstract][Full Text] [Related]
26. [The molecular genetics of meningiomas and genotypic/phenotypic correlations]. Dezamis E; Sanson M Rev Neurol (Paris); 2003 Sep; 159(8-9):727-38. PubMed ID: 13679715 [TBL] [Abstract][Full Text] [Related]
27. Lack of genetic and epigenetic changes in meningiomas without NF2 loss. van Tilborg AA; Morolli B; Giphart-Gassler M; de Vries A; van Geenen DA; Lurkin I; Kros JM; Zwarthoff EC J Pathol; 2006 Mar; 208(4):564-73. PubMed ID: 16353169 [TBL] [Abstract][Full Text] [Related]
28. Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas. De Vitis LR; Tedde A; Vitelli F; Ammannati F; Mennonna P; Bigozzi U; Montali E; Papi L Hum Genet; 1996 May; 97(5):632-7. PubMed ID: 8655144 [TBL] [Abstract][Full Text] [Related]
29. Epigenetic subclassification of meningiomas based on genome-wide DNA methylation analyses. Kishida Y; Natsume A; Kondo Y; Takeuchi I; An B; Okamoto Y; Shinjo K; Saito K; Ando H; Ohka F; Sekido Y; Wakabayashi T Carcinogenesis; 2012 Feb; 33(2):436-41. PubMed ID: 22102699 [TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of genetic alterations and methylation classes in meningioma. Berghoff AS; Hielscher T; Ricken G; Furtner J; Schrimpf D; Widhalm G; Rajky U; Marosi C; Hainfellner JA; von Deimling A; Sahm F; Preusser M Brain Pathol; 2022 Mar; 32(2):e12970. PubMed ID: 35213082 [TBL] [Abstract][Full Text] [Related]
32. Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features. Choudhury A; Chen WC; Lucas CG; Bayley JC; Harmanci AS; Maas SLN; Santagata S; Klisch T; Perry A; Bi WL; Sahm F; Patel AJ; Magill ST; Raleigh DR Neuro Oncol; 2023 Mar; 25(3):520-530. PubMed ID: 36227281 [TBL] [Abstract][Full Text] [Related]
33. Molecular analysis of alterations of the p18INK4c gene in human meningiomas. Santarius T; Kirsch M; Nikas DC; Imitola J; Black PM Neuropathol Appl Neurobiol; 2000 Feb; 26(1):67-75. PubMed ID: 10736068 [TBL] [Abstract][Full Text] [Related]
34. Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma. Harada T; Irving RM; Xuereb JH; Barton DE; Hardy DG; Moffat DA; Maher ER J Neurosurg; 1996 May; 84(5):847-51. PubMed ID: 8622160 [TBL] [Abstract][Full Text] [Related]
35. Clonal analysis of a case of multiple meningiomas using multiple molecular genetic approaches: pathology case report. Zhu JJ; Maruyama T; Jacoby LB; Herman JG; Gusella JF; Black PM; Wu JK Neurosurgery; 1999 Aug; 45(2):409-16. PubMed ID: 10449091 [TBL] [Abstract][Full Text] [Related]
36. The role and regulatory mechanism of IL-1β on the methylation of the NF2 gene in benign meningiomas and leptomeninges. Wang B; Cui Z; Zhong Z; Sun Y; Yang GY; Sun Q; Bian L Mol Carcinog; 2016 Dec; 55(12):2268-2277. PubMed ID: 26840621 [TBL] [Abstract][Full Text] [Related]
37. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas. Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069 [TBL] [Abstract][Full Text] [Related]
38. Genetic characterization and mutational profiling of foramen magnum meningiomas: a multi-institutional study. Hua L; Alkhatib M; Fujio S; Alhasan B; Herold S; Zeugner S; Zolal A; Hijazi MM; Clark VE; Wakimoto H; Shankar GM; Brastianos PK; Barker FG; Cahill DP; Ren L; Eyüpoglu IY; Gong Y; Schackert G; Juratli TA J Neurosurg; 2024 Jul; 141(1):72-78. PubMed ID: 38277657 [TBL] [Abstract][Full Text] [Related]
39. Involvement of epimutations in meningioma. Venza M; Visalli M; Beninati C; Catalano T; Biondo C; Teti D; Venza I Brain Tumor Pathol; 2015 Jul; 32(3):163-8. PubMed ID: 25930103 [TBL] [Abstract][Full Text] [Related]
40. Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes. Zhang X; Jia H; Lu Y; Dong C; Hou J; Wang Z; Wang F; Zhong H; Wang L; Wang K Discov Med; 2014 Dec; 18(101):301-311. PubMed ID: 25549701 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]